Serum CXCL10, CXCL11, CXCL12 and CXCL14 chemokine patterns in patients with acute liver injury

被引：0
作者：
Chalin, A. [1 ,2 ]
Lefevre, B. [1 ,2 ]
Devisme, C. [1 ,2 ]
Carriere, V. [1 ,2 ]
Amiot, L. [1 ,2 ,3 ]
Samson, M. [1 ,2 ]
机构：
[1] INSERM, U1085, IRSET, Rennes, France
[2] Univ Rennes 1, Rennes, France
[3] Univ Rennes 1, CHU Pontchaillou Rennes, Rennes, France
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)31447-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-510
引用
收藏
页码：S592 / S593
页数：2
相关论文
共 50 条
[31]   The Serum Level of CXCL9, CXCL10, and CXCL11 and the Expression of CXCR3 of Peripheral Blood Mononuclear Cells in Brucellosis Patients [J].
Hassanshahi, Farzaneh ;
Karimabad, Mojgan Noroozi ;
Miranzadeh, Elahe ;
Hassanshahi, Gholamhossein ;
Torabizadeh, Seyedeh Atekeh ;
Jebali, Ali .
CURRENT MICROBIOLOGY, 2023, 80 (06)
[32]   The Serum Level of CXCL9, CXCL10, and CXCL11 and the Expression of CXCR3 of Peripheral Blood Mononuclear Cells in Brucellosis Patients [J].
Farzaneh Hassanshahi ;
Mojgan Noroozi Karimabad ;
Elahe Miranzadeh ;
Gholamhossein Hassanshahi ;
Seyedeh Atekeh Torabizadeh ;
Ali Jebali .
Current Microbiology, 2023, 80
[33]   Chemokines CXCL10, CXCL11, and CXCL13 in acute disseminated encephalomyelitis, non-polio enterovirus aseptic meningitis, and neuroborreliosis: CXCL10 as initial discriminator in diagnostic algorithm? [J].
Maric, Lorna Stemberger ;
Lepej, Snjezana Zidovec ;
Gorenec, Lana ;
Grgic, Ivana ;
Trkulja, Vladimir ;
Rode, Oktavija Dakovic ;
Roglic, Srdan ;
Grmoja, Tonci ;
Barisic, Nina ;
Tesovic, Goran .
NEUROLOGICAL SCIENCES, 2018, 39 (03) :471-479
[34]   Chemokines CXCL10, CXCL11, and CXCL13 in acute disseminated encephalomyelitis, non-polio enterovirus aseptic meningitis, and neuroborreliosis: CXCL10 as initial discriminator in diagnostic algorithm? [J].
Lorna Stemberger Maric ;
Snjezana Zidovec Lepej ;
Lana Gorenec ;
Ivana Grgic ;
Vladimir Trkulja ;
Oktavija Dakovic Rode ;
Srdan Roglic ;
Tonci Grmoja ;
Nina Barisic ;
Goran Tesovic .
Neurological Sciences, 2018, 39 :471-479
[35]   Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum [J].
Mueller, M. ;
Carter, S. ;
Hofer, M. J. ;
Campbell, I. L. .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2010, 36 (05) :368-387
[36]   CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients [J].
Pineda-Tenor, Daniel ;
Berenguer, Juan ;
Jimenez-Sousa, Maria A. ;
Guzman-Fulgencio, Maria ;
Aldamiz-Echevarria, Teresa ;
Carrero, Ana ;
Garcia-Alvarez, Monica ;
Diez, Cristina ;
Tejerina, Francisco ;
Briz, Veronica ;
Resino, Salvador .
JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (03) :423-429
[37]   Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C [J].
Radmanic, Leona ;
Simicic, Petra S. ;
Bodulic, Kristian ;
Vince, Adriana ;
Zidovec- Lepej, Snjezana .
CYTOKINE, 2024, 176
[38]   Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection [J].
Chalin, Arnaud ;
Lefevre, Benjamin ;
Devisme, Christelle ;
Barget, Nathalie ;
Amiot, Laurence ;
Samson, Michel .
CYTOKINE, 2019, 117 :72-78
[39]   Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity [J].
Barbieri, Federica ;
Bajetto, Adriana ;
Dellacasagrande, Irene ;
Solari, Agnese ;
Wuerth, Roberto ;
Fernandez, Virginia ;
Rancati, Silvia ;
Ceresa, Davide ;
Appolloni, Irene ;
De Luca, Giuseppa ;
Dono, Mariella ;
Nozza, Paolo ;
Schiapparelli, Piero ;
Gambaro, Monica ;
Fiaschi, Pietro ;
Gaggero, Gabriele ;
Costanzo, Nicolo ;
Thellung, Stefano ;
Malatesta, Paolo ;
Pagano, Aldo ;
Zona, Gianluigi ;
De Pietri Tonelli, Davide ;
Florio, Tullio .
NEURO-ONCOLOGY, 2023, 25 (10) :1775-1787
[40]   Molecular cloning, characterization and expression analysis of a miiuy croaker (Miichthys miiuy) CXC chemokine gene resembling the CXCL9/CXCL10/CXCL11 [J].
Cheng, Yuan-zhi ;
Wang, Ri-xin ;
Xu, Tian-jun .
FISH & SHELLFISH IMMUNOLOGY, 2011, 31 (03) :439-445
12345